1. Home
  2. BGI vs OSRH Comparison

BGI vs OSRH Comparison

Compare BGI & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Birks Group Inc.

BGI

Birks Group Inc.

HOLD

Current Price

$0.81

Market Cap

14.1M

Sector

N/A

ML Signal

HOLD

Logo OSR Holdings Inc.

OSRH

OSR Holdings Inc.

HOLD

Current Price

$0.55

Market Cap

11.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGI
OSRH
Founded
1879
N/A
Country
Canada
United States
Employees
N/A
21
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
14.1M
11.7M
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
BGI
OSRH
Price
$0.81
$0.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
26.7K
810.2K
Earning Date
12-05-2025
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$9.30
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$0.38
52 Week High
$1.57
$1.79

Technical Indicators

Market Signals
Indicator
BGI
OSRH
Relative Strength Index (RSI) 58.04 58.19
Support Level $0.77 $0.55
Resistance Level $0.94 $0.60
Average True Range (ATR) 0.07 0.07
MACD 0.01 0.00
Stochastic Oscillator 80.95 66.11

Price Performance

Historical Comparison
BGI
OSRH

About BGI Birks Group Inc.

Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.

About OSRH OSR Holdings Inc.

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

Share on Social Networks: